Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
LOS ANGELES, Oct. 31, 2024 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
October 3, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring...
October 2, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: Alzheimer’s disease (“AD”) has become a focal point in the pharmaceutical industry as...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.6321 | -8.51852350983 | 7.4203 | 7.4282 | 6.43 | 201970 | 6.76323981 | CS |
| 4 | -2.4618 | -26.6140540541 | 9.25 | 10.54 | 6.43 | 229320 | 8.3397537 | CS |
| 12 | -1.9918 | -22.6856492027 | 8.78 | 10.54 | 6.43 | 232016 | 8.43261137 | CS |
| 26 | -1.9118 | -21.9747126437 | 8.7 | 17.88 | 4.53 | 977874 | 10.69769212 | CS |
| 52 | 0.7182 | 11.8319604613 | 6.07 | 22.49 | 4.53 | 709576 | 10.44561962 | CS |
| 156 | -20.3018 | -74.9420450351 | 27.09 | 27.1 | 4.53 | 281471 | 11.07422729 | CS |
| 260 | -2.1993 | -24.4706536857 | 8.9875 | 132 | 2.418 | 350625 | 25.56690004 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
